Cervical Medial Branch Block Versus Ipsilateral Cervical Erector Spinae Plane Block
Not yet recruitingNot applicableNCT07595406
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This prospective randomized controlled study aims to compare the analgesic effectiveness of ultrasound-guided cervical medial branch block and ipsilateral cervical erector spinae plane block in patients with cervical facetogenic pain. Patients with chronic cervical facet-mediated pain will be randomized into two intervention groups. Pain intensity, functional status, meaningful pain response rates, analgesic consumption, and patient satisfaction will be evaluated during follow-up. The primary objective is to determine whether cervical erector spinae plane block provides comparable short-term pain relief to cervical medial branch block.
Study details
- Official title
- Ultrasound-Guided Cervical Medial Branch Block Versus Ipsilateral Cervical Erector Spinae Plane Block in Cervical Facetogenic Pain: A Prospective Randomized Controlled Study
- Conditions
- Cervical Facetogenic Pain
- Chronic Neck Pain
- Cervical Facet Joint Syndrome
- Interventions
- Other: Ultrasound-guided cervical medial branch block
- Other: Ultrasound-guided cervical erector spinae plane block
- Sponsor
- Ankara City Hospital Bilkent
- Start date
- 2026-05-31
- Primary completion
- 2026-09-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age between 18 and 80 years * Chronic neck pain lasting at least 3 months * Clinical findings suggestive of cervical facetogenic pain * Numeric Rating Scale pain score ≥4 * Ability to provide informed consent Exclusion Criteria: * Cervical radiculopathy or myelopathy * Major neurological deficit * Infection at the injection site * Coagulopathy or anticoagulant therapy contraindicating intervention * Allergy to local anesthetics * Pregnancy * Previous cervical interventional pain procedure within the last 3 months * Severe psychiatric disease
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07595406